Day: May 7, 2023

Universities Around the World Compete to Improve Accessibility using Anthology Ally

Anthology’s Annual Global Fix Your Content Day is May 18 BOCA RATON, Fla., May 8, 2023 /PRNewswire/ — Anthology, a leading provider of education solutions that support the entire learner lifecycle, today announced its fourth annual Fix Your Content Day to highlight the need for more inclusive digital learning content. Anthology is inviting higher education institutions […]

BLISS BIOPHARMACEUTICAL ENTERS INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WITH AN OPTION OF STRATEGIC COLLABORATION WITH EISAI FOR BB-1701

HANGZHOU, China, May 8, 2023 /PRNewswire/ — Bliss Biopharmaceutical (Hangzhou) Co., Ltd, (“BlissBio”) a clinical-stage biopharmaceutical company developing differentiated antibody-drug conjugate (ADC) therapeutics, announced a clinical trial collaboration agreement with option for strategic collaboration with Eisai Co., Ltd. (“Eisai”), for BB-1701, eribulin-payload based ADC directed against Human Epidermal Growth Factor Receptor 2 (HER2) for the […]

Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study, including Japanese Sites

MELBOURNE, Australia and KYOTO, Japan, May 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to supply Illuccix® (TLX591-CDx, kit for the preparation of gallium Ga 68 gozetotide injection)[1] for the Phase III ARASTEP study (ClinicalTrials.gov Identifier: NCT05794906). This […]

Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study

MELBOURNE, Australia, May 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to supply Illuccix® (TLX591-CDx, kit for the preparation of gallium Ga 68 gozetotide injection)[1] for the Phase III ARASTEP study (ClinicalTrials.gov Identifier: NCT05794906). This global study is […]

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

Singapore’s Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST QINLOCK significantly reduced the risk of disease progression or death by 85% and showed clinically meaningful overall survival in the INVICTUS Phase 3 Study1,2 SINGAPORE, May 8, 2023 /PRNewswire/ — Independent biopharmaceutical company Specialised Therapeutics Asia (ST) […]

STL RESULT Today, Monday, May 8, 2023

STL RESULT TODAY – The STL Swer2, Swer3, and Pares draws held by Philippine Charity Sweepstakes Office (PCSO) for today, Monday, May 8, 2023, got these official results. Millions of people join the lotto games in the Philippines daily. The Philippine Charity Sweepstakes Office (PCSO) runs several major and minor lotto games. The STL games […]

LOTTO RESULT May 8, 2023 (6/55, 6/45)

LOTTO RESULT – The Philippine Charity Sweepstakes Office (PCSO) draws for 6/55 Grand Lotto and 6/45 Mega Lotto today, (May 8, 2023) yielded these results.. The Philippine Charity Sweepstakes Office or more commonly called PCSO is the government agency in the country that is in charge of the lotto draws. It has five (5) major […]

Back To Top